Harvard Business Review recently conducted an in-depth study at Lumere to gain insight into physicians’ perceptions of clinical variation and the factors influencing their choices of drugs and devices. Based on a survey of 276 physicians, our study results show that it’s necessary to consistently and frequently share cost data and clinical evidence with physicians, regardless of whether they’re affiliated with or directly employed by a hospital.
Read MoreEnd-of-life care is an important part of the care continuum for patients and the families of patients with terminal conditions or those encroaching upon old age. Palliative care is one option for end-of-life care and is specifically focused on symptom and pain management for patients with serious illnesses; it is not necessarily limited to patients in their last days or months of life and can be administered across a variety of care settings (from home to hospital)
Read MoreThe Oncology space offers an attractive market opportunity for the rapidly growing number of cancer-focused startups. The transition to value-based reimbursement is fueling this market opportunity by pressuring providers to improve processes and reduce costs.
Read MorePlease enjoy this report on the Outsourced Care Management Industry. This is an area of the healthcare industry that FCA is interested in investing in. The report was put together by Dillon Vess, who is currently completing his MBA at Vanderbilt.
Read MorePlease enjoy this report on the effects of Blockchain in the Healthcare industry. The report was put together by FCA's all star interns, Roja Garimella and Sean O'Donnell, and our Associate, Grant Blevins.
Read MoreFCA Venture Partners is especially interested in solutions addressing the treatment of Opioid prescription drug abuse. We are interested in meeting with any startup that has a solution addressing this problem. In an effort to show our thought leadership, we worked with Vanderbilt MBA student, Orin Brown, to put together this report.
Read More